MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Discover the role of genetic testing in diagnosing Progressive Childhood Encephalopathy, guiding treatment strategies, and assisting with family planning. Learn more about this…
Discover the role of genetic testing in understanding prostate cancer susceptibility, early detection, personalized treatment, and family planning strategies.
Discover the importance of collagen 6 defects, their diagnosis, and how genetic testing can aid in treatment, family planning, and advancing research for a better future.
Discover the importance of understanding rare genetic deafness, its diagnosis, and how genetic testing plays a crucial role in treatment, family planning, and research.
Discover the importance of genetic testing in diagnosing rare genetic intellectual disabilities, guiding treatment, informing family planning, and connecting with support networks.
Discover the importance of genetic testing for rare syndromic intellectual disabilities, aiding in accurate diagnosis, targeted treatment, and prenatal testing.
Discover the role of genetic testing in diagnosing Ras-associated cancers, predicting treatment response, and personalizing Ras inhibitor therapy for improved outcomes.
Discover the role of genetic testing in predicting regorafenib response for personalized cancer treatment plans, improved patient outcomes, and reduced healthcare costs.